Dyne Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Dyne Therapeutics (NASDAQ: DYN), a clinical-stage company specializing in treatments for genetically driven neuromuscular diseases, has announced its participation in two major healthcare investor conferences in September 2025.

Management will present at the Cantor Global Healthcare Conference on September 5, 2025, at 9:45 a.m. ET, and at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 9:15 a.m. ET. Both events will take place in New York.

Investors can access live webcasts of the presentations through Dyne's website, with replays available for 90 days.

News Market Reaction – DYN

+1.94%

1 alert

+1.94% News Effect

On the day this news was published, DYN gained 1.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:

• Cantor Global Healthcare Conference 2025, fireside chat on Friday, September 5, 2025 at 9:45 a.m. ET in New York
• Morgan Stanley 23^rd Annual Global Healthcare Conference, fireside chat on Monday, September 8, 2025 at 9:15 a.m. ET in New York

A live webcast of each presentation will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.

About Dyne Therapeutics
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Contacts:
Investors
Mia Tobias
ir@dyne-tx.com
781-317-0353

Media
Stacy Nartker 
snartker@dyne-tx.com
781-317-1938

FAQ

When is Dyne Therapeutics (DYN) presenting at the Cantor Global Healthcare Conference 2025?

Dyne Therapeutics will present a fireside chat at the Cantor Global Healthcare Conference on Friday, September 5, 2025 at 9:45 a.m. ET in New York.

What time is Dyne Therapeutics' presentation at the Morgan Stanley Healthcare Conference 2025?

Dyne Therapeutics will present a fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 8, 2025 at 9:15 a.m. ET in New York.

Where can I watch Dyne Therapeutics' (DYN) investor conference presentations?

The presentations can be accessed via live webcast in the Investors & Media section of Dyne's website at investors.dyne-tx.com. Replays will be available for 90 days after the events.

What type of company is Dyne Therapeutics (DYN)?

Dyne Therapeutics is a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.